businesspress24.com - Vaccines' Allure Remains Solid for Pharma, Attracting $2.5 Billion in North American Capital In
 

Vaccines' Allure Remains Solid for Pharma, Attracting $2.5 Billion in North American Capital Investment, an Industrial Info News Alert

ID: 1106900

(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 04/25/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Vaccines continue to attract the drug industry for the same reasons as they always have. The vaccines sector is a darling in that there always seems to be some government funding involved. That particular flow has been staunched a bit, but this is not expected to last, as the clamor for vaccines never really dissipates. By the end of 2012, the global vaccine market is expected to hit $34 billion in sales. With an estimated annual growth rate of 14% during the next five years, it is believed that vaccines will be the fastest growing therapeutic area, eventually outpacing oncology.

Companies featured: (NYSE:MRK), (NYSE:GSK), (NASDAQ:SNY), (NYSE:PFE), (NASDAQ:NVS)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.





Contact:
Joe Govreau
713-783-5147




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Precision BioSciences Files Tenth Patent Infringement Lawsuit Against Cellectis Related to Meganuclease Technology and Requests Permanent Injunction
Threshold Pharmaceuticals Appoints Robert Simon as Senior Vice President of Regulatory Affairs
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 25.04.2012 - 04:40 Uhr
Sprache: Deutsch
News-ID 1106900
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SUGAR LAND, TX


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 161 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Vaccines' Allure Remains Solid for Pharma, Attracting $2.5 Billion in North American Capital Investment, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von

Industrial Info Resources (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Industrial Info Resources



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 78


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.